FDA Media Briefing on Asthma Drugs

Friday, February 19, 2010 Drug News
Email Print This Page Comment
Font : A-A+

** CREDENTIALED PRESS ONLY **

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

WHAT:

A media briefing on new safety controls

for long-acting beta agonists, medications used to treat asthma

WHO:

--Janet Woodcock, M.D., director, Center for Drug Evaluation and Research (CDER), FDA

--John

Jenkins, M.D., director, Office of New Drugs, CDER, FDA

--Gerald Dal Pan, M.D., director, Office of Surveillance and Epidemiology, CDER, FDA

--Badrul Chowdhury, M.D., director, Division of Pulmonary and Allergy Products, Office of Drug Evaluation II, CDER, FDA

--Sally Seymour, M.D., deputy director for safety, Division of Pulmonary and Allergy Products, Office of Drug Evaluation II, CDER

WHEN:

Thurs., Feb. 18, 2010, 1:15 p.m. EST

HOW:

Reporters may participate in a listen-only mode by dialing 888-455-0031 or for international reporters, 1-312-470-0068. The password for all callers is "FDA." A replay of the briefing will be available until Feb. 25 by calling 888-562-2793 or for international reporters, 1-402-998-1450.

CONTACT: Karen Riley, 301-796-4674 (office), karen.riley@fda.hhs.gov, or Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov, both of FDA

/PRNewswire-USNewswire -- Feb. 18/

SOURCE U.S. Food and Drug Administration



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook